Medicare’s Hospital Value-Based Purchasing program has not accelerated the improvement of patient experience beyond previous trends, according to a study reported this week in Health Affairs. “Instead, we found that the rate of improvements in patient experience has slowed since the program was implemented,” the authors said. “Over the entire study period, certain subsets of hospitals (such as small ones) seemed to have improved in patient experience more than other subsets (such as larger hospitals), yet even for the institutions that had greater improvement, the majority of the change occurred before implementation of the VBP program.” The study examined trends in multiple measures of patient satisfaction between 2008 and 2014. The Centers for Medicare & Medicaid Services began publicly reporting on patient-reported experience through the Hospital Consumer Assessment of Healthcare Providers and Systems survey in 2008, and tied Medicare payments directly to these measures through the VBP program in 2011. The authors said the study “adds to a growing body of literature suggesting that U.S. pay-for-performance schemes have had little to no effect on driving meaningful improvements in other patient outcomes.”

Headline
The AHA’s Living Learning Network, in partnership with the Centers for Disease Control and Prevention, July 22 released “Rural Sepsis Care in Action: Real-…
Headline
The Centers for Medicare & Medicaid Services has released an updated FAQ on Protecting Access to Medicare Act private payer data reporting. The deadline is…
Headline
The Centers for Medicare & Medicaid Services July 16 released draft guidance for the 2028 cycle of negotiations under the Medicare Drug Price Negotiation…
Headline
The Centers for Disease Control and Prevention July 14 released an advisory on the growing cyclosporiasis cases across the U.S. The advisory said that the…
Headline
The Centers for Disease Control and Prevention has reported 843 cases of cyclosporiasis across 31 states, with 86 people hospitalized. State health departments…
Headline
The Food and Drug Administration has issued an early alert for specific lots of BD ChloraPrep Applicators by Medline because of a potential breach of sterility…